Artichoke Leaf Extract: Digestive Trials and Safety
Artichoke leaf extract has a preliminary dyspepsia signal from a manufacturer-sponsored trial, rated low certainty by Cochrane. IBS reports lack placebo controls and complete diagnostic safeguards. Liver studies are small and short; one has allocation and participant-reporting problems, and another shows time-specific imaging changes alongside a higher AST marker. Commercial relationships and unknown procurement terms remain distinct. Specified traditional medicines have important biliary, liver, allergy and medication restrictions. These findings do not establish SIBO treatment, a liver detox, universal product equivalence or a safe general dose.
